86 results on '"Preiss, R."'
Search Results
2. The impact of time from diagnosis at baseline on long-term outcome in the GRIPHON Study: Selexipag in pulmonary arterial hypertension (PAH)
3. A rough path perspective on renormalization
4. THE IMPACT OF TIME FROM DIAGNOSIS AT BASELINE ON LONG-TERM OUTCOME IN THE GRIPHON STUDY: SELEXIPAG IN PULMONARY ARTERIAL HYPERTENSION (PAH)
5. 4973Efficacy and safety of selexipag in pulmonary arterial hypertension (PAH) patients with and without significant cardiovascular (CV) comorbidities
6. The Impact of Time from Diagnosis at Baseline on Long-Term Outcome in the GRIPHON Study: Selexipag in Pulmonary Arterial Hypertension
7. Risk assessment in pulmonary arterial hypertension (PAH): Insights from the GRIPHON study
8. S122 Long-term survival and safety with selexipag in patients with pulmonary arterial hypertension: results from the GRIPHON study and its open-label extension
9. Pulmonary arterial hypertension-related morbidity is prognostic for survival: Insights from the SERAPHIN and GRIPHON studies
10. Cibler la voie de la prostacycline dans le traitement des HTAP associées aux connectivites : expérience de Griphon – étude contrôlée, randomisée avec le selexipag
11. S109 Targeting the prostacyclin pathway in the treatment of connective tissue disease associated pulmonary arterial hypertension (pah): insights from the randomised controlled griphon trial with selexipag
12. SELEXIPAG FOR PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE (PAH-CHD) AFTER DEFECT CORRECTION: INSIGHTS FROM THE RANDOMISED CONTROLLED GRIPHON STUDY
13. Anticoagulant Therapy Is Not Associated with Long Term Outcome in Patients with Pulmonary Arterial Hypertension (PAH): Insights from the GRIPHON Study
14. Effekt von Selexipag auf den primären kombinierten Morbiditäts- und Mortalitätsendpunkt in Abhängigkeit von vorbestehenden PAH-Therapien, Ätiologie, Alter und geographischer Region: Ergebnisse der GRIPHON Studie
15. Phase-I-Studie zur Behandlung von hilären Gallengangskarzinomen mit Bendamustin
16. Effect of Selexipag on Morbidity/Mortality in Pulmonary Arterial Hypertension: Results of the GRIPHON Study
17. INVESTIGATION ON TIME-DEPENDENT PHARMACOKINETICS OF ADRIAMYCIN IN PATIENTS WITH DIFFERING LIVER STATUS
18. Investigation of the Hay-Technique of the High Jump by Computer Simulation
19. Control of Flight Speed by Minimization of the Apparent Ground Pattern Movement
20. Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients
21. Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes
22. Cytokines and inflammatory mediators: 25. Certolizumab Pegol has a Different Profile from the other Anti-TNFS, Including Golimumab, in a Variety of in Vitro Assays
23. Concurrent Oral 1 - Therapy of rheumatic disease: OP4. Effectiveness of Rituximab in Rheumatoid Arthritis: Results from the British Society for Rheumatology Biologics Register (BSRBR)
24. The use of modular femoral head trials to centre the Explant blade facilitates retrieval of well-fixed acetabular components with minimal bone loss
25. Vascularized fibular graft arthrodesis as salvage for severe bone loss following failed revision total elbow replacement
26. Miscellaneous Rheumatic Diseases [73-83]: 73. Is There a Delay in Specialist Referral of Hot Swollen Joint?
27. Cytokines and Inflammatory Mediators [30-39]: 30. The LPS Stimulated Production of Interleukin-10 is not Associated with -819C/T and -592C/A Promoter Polymorphisms in Healthy Indian Subjects
28. Determination of nicotine and cotinine in human serum by means of LC/MS
29. Résultats à un an du canakinumab (ACZ885, anticorps monoclonal humain anti-IL1ß) chez des patients atteints de syndrome périodique associé à une cryopyrinopathie (CAPS)
30. Determination of terephthalic acid isopropylamide in urine with a liquid chromatography/mass spectrometry (LC/MS) method
31. Evaluation of the pharmacokinetics of dalteparin in patients with renal insufficiency
32. Modeling of the Pstn Channel and Multireferences Training in Robust Speech Recognition
33. Modelisation du canal telephonique pstn et apprentissage multireferences en reconnaissance robuste de la parole
34. Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways
35. D2 dopamine receptor occupancy, risperidone plasma level and extrapyramidal motor symptoms in previously drug-free schizophrenic patients
36. FTY720, A SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST, HAS NO ADVERSE EFFECTS ON CARDIAC CONDUCTION OR RHYTHM IN MAINTENANCE RENAL TRANSPLANT PATIENTS
37. CYP3A4, CYP2C9 and CYP2B6 expression and ifosfamide turnover in breast cancer tissue microsomes
38. CYP2C and IL-6 expression in breast cancer
39. THE EFFECTS OF BOTULINUM TOXIN (BTX-A) ON SPASTICITY OF THE LOWER LIMB AND ON GAIT IN CEREBRAL PALSY
40. Letters to the Editor
41. People with partial hearing need to seek hearing potential
42. Cyclophosphamide and related anticancer drugs
43. IL-1 receptor type I expression in breast cancer
44. Gender difference in ifosfamide metabolism by human liver microsomes
45. In vitro tolerance to inhibition by ethanol of N-methyl-d-aspartate-induced depolarization in locus coeruleus neurons of behaviorally ethanol-tolerant rats
46. Pharmacokinetics of oral talinolol following a single dose and during steady state in patients with chronic renal failure and healthy volunteers
47. Design-by-analysis of a chemical reactor's head under sustained and thermal loads
48. Modulation of multidrug resistance in human leukemia cells with mdr1-targeted antisense oligonucleotides using variable treatment schedules
49. Cisplatin (CDDP)-induced radiation resistance is not associated with CDDP resistance in 86HG39 and A172 malignant glioma cells
50. Survival after massive "ecstasy" (MDMA) ingestion
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.